本文报告以抗人胸腺细胞球蛋白治疗9例单纯红细胞再生障碍性贫血的疗效。治疗1～3疗程后,完全缓解6/9例,部分缓解2/9例,总有效率89%。该疗法具有疗效快,副反应少等特点,对已经其他治疗无效的纯红再障有较好疗效。 This article reports the anti-human thymocyte globulin treatment of 9 cases of erythrocyte aplastic anemia curative effect. After treatment for 1 to 3 courses of treatment, 6/9 patients were completely relieved, 2/9 patients partially relieved, and the total effective rate was 89%. The therapy has the advantages of fast response, less side effects and the like, and has good curative effect on pure aplastic anemia which has been invalidated by other treatments.